免疫检查点抑制剂联合抗血管生成靶向药物治疗晚期肝细胞癌20例临床观察Clinical Observation of Immunotherapy Combined with Antiangiogenic Targeted Drugs in the Treatment of 20 Cases Advanced Hepatocellular Carcinoma
刘 永, 李俐姗, 李红梅, 冷 洁 科研立项经费支持
临床医学进展Vol.13 No.2, 全文下载: PDF HTML XML DOI:10.12677/ACM.2023.132364, February 22 2023
基于TCGA数据库的肝癌发生关键基因筛选Identification Key Genes of Hepatocellular Carcinoma Base on TCGA Database
贾俊君, 何 宁, 张 静, 姜 骊, 周燕飞, 周 琳, 郑树森 国家科技经费支持
外科Vol.4 No.1, 全文下载: PDF HTML XML DOI:10.12677/HJS.2015.41001, January 2 2015
HBV相关肝癌的CD8+T细胞抗肿瘤免疫机制研究进展Research Progress on Anti-Tumor Immune Mechanism of CD8+T Cells in HBV-Related Hepatocellular Carcinoma
任丹丹, 马金鑫
临床医学进展Vol.11 No.5, 全文下载: PDF HTML XML DOI:10.12677/ACM.2021.115338, May 27 2021
抗血管生成治疗中晚期宫颈癌的研究进展Advances in Anti-Angiogenesis Therapy for Middle and Advanced Cervical Cancer
位 凤, 张晓兰
临床医学进展Vol.13 No.8, 全文下载: PDF HTML XML DOI:10.12677/ACM.2023.1381884, August 23 2023
阿帕替尼在肝细胞癌治疗中的临床研究进展Clinical Research Progress of Apatinib in the Treatment of Hepatocellular Carcinoma
冯 源, 涂 兵, 李思朋
临床医学进展Vol.11 No.12, 全文下载: PDF HTML XML DOI:10.12677/ACM.2021.1112919, December 31 2021
影响PT2N0M0期胸段食管鳞癌术后失败的COX多因素分析结果及其对术后辅助治疗的指导意义Analysis of Postoperative Failure in Patients with Stage PT2N0M0 Esophageal Squamous Cell Carcinoma and Its Guiding Significance for Postoperative Adjuvant Therapy
段有升, 张宏毅, 杨红杰, 陶 鹤, 沈文斌
临床医学进展Vol.11 No.3, 全文下载: PDF HTML XML DOI:10.12677/ACM.2021.113170, March 22 2021